Discover
AQST
Aquestive Therapeutics, Inc.
3.98
16 x 3.98
22 x 3.99
bid
ask
-
0.06
1.36%
12:08 PM
timesize
| Ytd | -38.31% | |
| 1y | 0.38% |
3.93
day range
4.07
2.93
52 week range
7.55
| Open | 4.04 | Prev Close | 4.04 | Low | 3.93 | High | 4.07 | Mkt Cap | 401.20M |
| Vol | 486.57K | Avg Vol | 1.85M | EPS | -0.61 | P/E | -6.62 | Forward P/E | -5.87 |
| Beta | 1.45 | Short Ratio | 6.37 | Inst. Own | 55.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 4.21 | 200-d Avg | 4.80 | 1yr Est | 10.83 |
| Income Statement | |||
| Total Revenue | 14.45M | ||
| Revenues (USD) | 14.45M | ||
| Cost of Revenue | 3.47M | ||
| Gross Profit | 10.98M | ||
| Operating Expenses | 15.18M | ||
| Research and Development Expense | 4.20M | ||
| Selling, General and Administrative Expense | 10.98M | ||
| Operating Income | -4.20M | ||
| Interest Expense | 3.94M | ||
| Net Income | -8.06M | ||
| Net Income Common Stock | -8.06M | ||
| Net Income Common Stock (USD) | -8.06M | ||
| Consolidated Income | -8.06M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -4.12M | ||
| Earning Before Interest & Taxes (USD) | -4.12M | ||
| Weighted Average Shares | 122.61M | ||
| Weighted Average Shares Diluted | 122.61M | ||
| Balance Sheet | |||
| Cash and Equivalents | 110.73M | ||
| Cash and Equivalents (USD) | 110.73M | ||
| Trade and Non-Trade Receivables | 6.87M | ||
| Current Assets | 130.18M | ||
| Property, Plant & Equipment Net | 8.31M | ||
| Total Assets | 141.13M | ||
| Debt Current | 15.32M | ||
| Total Debt | 133.58M | ||
| Current Liabilities | 31.75M | ||
| Debt Non-Current | 118.26M | ||
| Total Liabilities | 175.18M | ||
| Accumulated Retained Earnings (Deficit) | -455.05M | ||
| Shareholders Equity | -34.05M | ||
| Shareholders Equity (USD) | -34.05M | ||
| Assets Non-Current | 10.94M | ||
| Total Debt (USD) | 133.58M | ||
| Deferred Revenue | 20.21M | ||
| Inventory | 8.07M | ||
| Liabilities Non-Current | 143.43M | ||
| Trade and Non-Trade Payables | 11.89M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 113.00K | ||
| Net Cash Flow from Financing | 4.42M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.43M | ||
| Capital Expenditure | -52.00K | ||
| Issuance (Purchase) of Equity Shares | 4.76M | ||
| Issuance (Repayment) of Debt Securities | -8.00K | ||
| Net Cash Flow from Investing | -52.00K | ||
| Net Cash Flow from Operations | -14.81M | ||
| Share Based Compensation | 2.32M | ||